France-based food company Danone has revealed its strategic plans to enter the adult foods for special medical purposes (aFSMP) category in China. This move marks a significant expansion for the firm, which intends to manufacture its products locally, beginning with the launch of Fortimel, a high-protein, high-energy oral nutritional supplement designed to address disease-related malnutrition.
Fortimel’s Launch and Impact
The launch of Fortimel this week signifies Danone’s commitment to providing nutritional solutions in China. Fortimel is a compact oral nutritional supplement that caters to the needs of patients recovering from surgery or managing non-communicable diseases such as cancer or stroke. The product is poised to play a crucial role in supporting the nutritional requirements of this demographic.
Danone’s Existing Presence in Chinese Hospitals
Danone is already well-established in China’s healthcare sector, providing its Nutrison and Peptisorb tube-feeding products to 90% of the leading hospitals in the country. This existing presence positions Danone favorably as it introduces Fortimel to the Chinese market, leveraging its reputation for quality and nutritional excellence.
Expanding Nutritional Solutions
With the aFSMP category, Danone is further expanding its range of nutritional solutions tailored for adult patients with specific dietary needs. The introduction of Fortimel in China not only diversifies the company’s product portfolio but also aligns with the growing demand for specialized nutritional products in the country.-Fineline Info & Tech
